Coston McIsaac & Partners’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9K | Hold |
74
| – | – | ﹤0.01% | 539 |
|
|
2025
Q1 | $9K | Hold |
74
| – | – | ﹤0.01% | 513 |
|
|
2024
Q4 | $9K | Hold |
74
| – | – | ﹤0.01% | 495 |
|
|
2024
Q3 | $10 | Hold |
74
| – | – | ﹤0.01% | 492 |
|
|
2024
Q2 | $10K | Sell |
74
-40
| -35% | -$5.41K | ﹤0.01% | 468 |
|
|
2024
Q1 | $15K | Hold |
114
| – | – | ﹤0.01% | 423 |
|
|
2023
Q4 | $15K | Hold |
114
| – | – | 0.01% | 427 |
|
|
2023
Q3 | $13K | Hold |
114
| – | – | ﹤0.01% | 441 |
|
|
2023
Q2 | $14K | Hold |
114
| – | – | ﹤0.01% | 457 |
|
|
2023
Q1 | $14K | Sell |
114
-151
| -57% | -$18.5K | 0.01% | 457 |
|
|
2022
Q4 | $34 | Buy |
265
+151
| +132% | +$19 | 0.01% | 336 |
|
|
2022
Q3 | $13K | Hold |
114
| – | – | 0.01% | 395 |
|
|
2022
Q2 | $13K | Buy |
+114
| New | +$13K | 0.01% | 251 |
|